Lifevantage (NASDAQ:LFVN) vs. Solesence (NASDAQ:SLSN) Head to Head Analysis

Solesence (NASDAQ:SLSN – Get Free Report) and Lifevantage (NASDAQ:LFVN – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Profitability

This table compares Solesence and Lifevantage’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Solesence 4.77% 18.27% 6.05%
Lifevantage 1.58% 16.35% 8.90%

Valuation & Earnings

This table compares Solesence and Lifevantage”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Solesence $62.06 million 1.73 $1.79 million $0.04 38.00
Lifevantage $182.59 million 0.35 $5.07 million $0.21 23.67

Lifevantage has higher revenue and earnings than Solesence. Lifevantage is trading at a lower price-to-earnings ratio than Solesence, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Solesence and Lifevantage, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solesence 1 0 0 0 1.00
Lifevantage 1 2 1 0 2.00

Lifevantage has a consensus price target of $6.75, indicating a potential upside of 35.81%. Given Lifevantage’s stronger consensus rating and higher possible upside, analysts plainly believe Lifevantage is more favorable than Solesence.

Volatility & Risk

Solesence has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Lifevantage has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500.

Institutional & Insider Ownership

70.2% of Solesence shares are held by institutional investors. Comparatively, 35.3% of Lifevantage shares are held by institutional investors. 4.8% of Solesence shares are held by company insiders. Comparatively, 13.6% of Lifevantage shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Lifevantage beats Solesence on 8 of the 14 factors compared between the two stocks.

About Solesence

(Get Free Report)

Solesence is a beauty and skincare product development and manufacturing company. It works with brands to formulate and produce products, with capabilities spanning product development, regulatory support and manufacturing. The company’s offerings include sunscreens, skincare products and color cosmetics, including mineral-based sun-protection formulations. Its work supports brands seeking product development and production services rather than focusing solely on sales under a single consumer brand.

About Lifevantage

(Get Free Report)

LifeVantage Corporation is a health and wellness company that develops and sells dietary supplements, skincare products and other wellness offerings. Its product range includes Protandim supplements and the TrueScience skincare line, with products marketed around the company’s focus on nutrigenomics—the study of how nutrition interacts with gene expression. Founded in 2003, LifeVantage primarily sells through independent consultants and online channels. The company serves customers in markets across North America, Europe and the Asia-Pacific region.

Receive News & Ratings for Solesence Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solesence and related companies with MarketBeat.com's FREE daily email newsletter.